Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (12) Daniel, Peter Prof. Dr. (1) Ittermann, Bernd Dr. (2) Kammertöns, Thomas Dr. (3) Leisegang, Matthias Prof. Dr. rer. nat. (2) Paul, Friedemann Prof. Dr. med. (20) Uckert, Wolfgang Prof. Dr. (3) Waiczies, Helmar Dr. (2) Waiczies, Sonia PD Dr. (1) (-) Kopp, Joachim Dr. (2) (-) Niendorf, Thoralf Prof. Dr. (1) (-) Pezzutto, Antonio Prof. Dr. (3) (-) Willimsky, Gerald Dr. (5) 1997 (2) 1998 (3) 1999 (1) 2000 (4) 2002 (1) 2004 (1) 2005 (4) 2007 (1) 2008 (2) (-) 2010 (4) (-) 2011 (2) 2012 (3) 2013 (7) 2014 (5) 2015 (5) 2016 (4) 2017 (2) 2018 (5) 2019 (3) 2020 (2) 2022 (2) 2023 (4) AG Müller/Dechend (ECRC) (38) Anchored Signalling (1) Animal Phenotyping (1) Cardiac MRI (11) Cellular Neurosciences (1) Experimental Ultrahigh-Field MR (10) Genetics and Genomics of Cardiovascular Diseases (2) Genome Diversification & Integrity (4) Hypertension-caused End-Organ Damage (38) Hypertension-Mediated End-Organ Damage (38) Magnetic Resonance (10) Mathematical Cell Physiology (10) Mathematical Modelling of Cellular Processes (1) Molecular Biology of Peptide Hormones (2) (-) Molecular Immunology and Gene Therapy (5) Molecular Physiology of Somatic Sensation (1) Myology (1) (-) Out-patient Clinic for Neuroimmunology (1) 6 Results: Active Filter: Kopp, Joachim Dr.Niendorf, Thoralf Prof. Dr.Pezzutto, Antonio Prof. Dr.Willimsky, Gerald Dr.Molecular Immunology and Gene TherapyOut-patient Clinic for Neuroimmunology20102011 Sort: Result score Newest to oldest Oldest to newest March 15, 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein April 01, 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto September 01, 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler December 16, 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein July 19, 2011 / PLoS ONE Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells H. Waiczies S. Lepore N. Janitzek U. Hagen F. Seifert B. Ittermann B. Purfürst A. Pezzutto F. Paul T. Niendorf S. Waiczies March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
March 15, 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein
April 01, 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
September 01, 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler
December 16, 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein
July 19, 2011 / PLoS ONE Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells H. Waiczies S. Lepore N. Janitzek U. Hagen F. Seifert B. Ittermann B. Purfürst A. Pezzutto F. Paul T. Niendorf S. Waiczies
March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel